Oxford Cannabinoid Technologies Holdings Plc Stock
Equities
OCTP
GB00BMVMRB86
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.35 GBX | +1.45% | -2.78% | -44.00% |
Apr. 11 | Oxford Cannabinoid teams with iNGENu to test OCT130401 pain treatment | AN |
Apr. 09 | Oxford Cannabinoid Technologies Holdings plc Appoints Timothy Henry Corn as A Director | CI |
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 3.81M 4.76M |
---|---|---|---|---|---|
Net income 2024 * | -2M -2.5M | Net income 2025 * | -3M -3.75M | EV / Sales 2024 * | - |
Net cash position 2024 * | 1.18M 1.48M | Net Debt 2025 * | 2.03M 2.53M | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-1.59
x | P/E ratio 2025 * |
-1.21
x | Employees | 7 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 70.17% |
1 day | +1.45% | ||
1 week | -2.78% | ||
Current month | -2.78% | ||
1 month | -9.09% | ||
3 months | -31.37% | ||
6 months | -50.00% | ||
Current year | -44.00% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 44 | - | |
Paul Smalley
DFI | Director of Finance/CFO | - | 22-10-16 |
Chief Tech/Sci/R&D Officer | 55 | 20-06-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 66 | - | |
Julie Pomeroy
CHM | Chairman | 69 | - |
Timothy Corn
CTO | Chief Tech/Sci/R&D Officer | 73 | 23-06-07 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-07 | 0.35 | +1.45% | 2,214,203 |
24-05-03 | 0.345 | -1.43% | 751,855 |
24-05-02 | 0.35 | -2.78% | 2,026,255 |
24-05-01 | 0.36 | 0.00% | 1,608,204 |
24-04-30 | 0.36 | -1.37% | 8,510,620 |
Delayed Quote London S.E., May 07, 2024 at 11:35 am EDT
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-44.00% | 4.78M | |
+21.74% | 46.4B | |
-0.97% | 41.75B | |
+47.07% | 41.37B | |
-3.52% | 29.71B | |
+11.12% | 26.01B | |
-19.37% | 19.52B | |
+31.18% | 12.43B | |
-0.04% | 12.13B | |
+0.39% | 12.18B |
- Stock Market
- Equities
- OCTP Stock